2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow danoprevir: new trials by email Literature Review of danoprevir trials Research Report on danoprevir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects. Ravidasvir, Danoprevir, Ritonavir - HCV | Phase 2 / Phase 3 | Completed | Ascletis Pharmaceuticals Co., Ltd. | 425 | 2017-07-01 | 2020-07-28 |
| Efficacy and Safety of Danoprevir/r + PR 12week Triple Therapy in Treatment Naive Non-Cirrhotic G1 CHC China III Danoprevir, Ritonavir, peginterferon alfa-2a - Chronic Hepatitis C | Phase 3 | Completed | Ascletis Pharmaceuticals Co., Ltd. | 141 | 2016-06-01 | 2021-03-23 |
Ascletis Pharmaceuticals Co., Ltd. (2)
China (1)
Huoling Tang, PhD (1) · Yahong Chen, Master (1)